Hyperoxia on Ventilation During Recovery From General Anesthesia
NCT ID: NCT05922020
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-08-08
2023-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
NCT05379673
Towards RECOVER: Outcomes and Needs Assessment in Intensive Care Unit (ICU) Survivors of Prolonged Mechanical Ventilation and Their Caregivers
NCT00896220
Effects of Different Inhalation Oxygen Concentrations on Postoperative Atelectasis
NCT05627024
Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.
NCT05689216
Evaluation of Oxygen Consumption and Energy Expenditure During Spontaneous Breathing Trial.
NCT01757093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
More specifically, patients treated with hyperoxia (O2 titrated to: SpO2 \> 96%, N=10; Liberal O2) for 90 minutes post-anesthesia, spent 61.2% of the time at TcPCO2 \> 45 mmHg, compared with 80.6% of the time in those receiving standard O2 supplementation (O2 titrated to: SpO2 between 90-94%, N=9; Conservative O2 - between-group difference of 19.4% (95% Confidence Intervals: -18.7% to 57.6%), ANCOVA adjusted P = 0.140\]. Results were consistent across the 90-min monitoring period. With an observed effect size of 0.73, it was estimated that 30 participants per group are required, to demonstrate this difference with a power of 80% at a two-sided alpha of 5%.
In a follow-up RCT (IRB-63878, NCT05379673) in 18 patients the investigators found that over a 90-minute window, the average percentage of time spent at TcPCO2 \> 45mmHg for patients in the Conservative O2 group (N=9) was 57.8% (52 ± 44 minutes), compared with a 45.6% (41 ± 46 minutes) for those in the Liberal O2 group (N=9), (P=0.6134; two-sided two sample t-test). In addition, during the same period, respiratory disturbance index (RDI; events per hour) was higher in the Conservative O2 \[median (range): 23.9 (11.0-78.6)\], compared with the Liberal O2 group \[19.6 (2.8-40.4), Mann-Whitney test, P=0.1615\].
Due to the high variability observed in the evaluated respiratory parameters (i.e., TcPCO2 and upper airway obstruction expressed by Respiratory Disturbance Index), the researchers believe that a crossover, rather than a randomized controlled trial, design would improve the power and efficiency of this investigation and also provide an opportunity to characterize better those patients who respond, and separate them from those who do not respond to hyperoxia treatment.
This preliminary investigation will assess how ventilation during recovery from general anesthesia is affected by conservative (Conservative O2: 90% ≤ SpO2 ≤ 94%), compared with liberal (Liberal O2: SpO2 \> 96%) O2 supplementation. Using a crossover study design, the investigators aim to: a) assess the breathing pattern and estimate and compare the number of apnea/hypopnea episodes between the two interventions, and b) estimate and compare the cumulative segment of time during which the transcutaneous partial pressure of carbon dioxide (TcPCO2) will exceed 45 mmHg, between the two interventions.
Hypothesis: Conservative O2 will be associated with more unstable and obstructed breathing and less time spent with TcPCO2 \> 45 mmHg, compared with Liberal O2 supplementation, during recovery from anesthesia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
2. The investigator who will regulating the O2 inspired concentration-related intervention, will be blinded to the continuous TcPCO2 measurement. In addition, the sleep medicine specialist who will assess the breathing pattern offline and score the number and nature of apnea/hypopnea episodes, will also be blinded to the treatment arm.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"Conservative O2"
During the first treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 between 90% and 94%.
Oxygen gas
Administration of Oxygen by inhalation
"Liberal O2"
During the second treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 \> 96%.
Oxygen gas
Administration of Oxygen by inhalation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxygen gas
Administration of Oxygen by inhalation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) less than 35 kg/m2
* Scheduled to undergo robotic-assisted radical laparoscopic nephrectomy.
Exclusion Criteria
* Chronic pain condition that is being treated with opioids
* Patients with a hematocrit lower than 30% at the end of surgery, or those with an excessive blood loss, requiring transfusion of blood products during surgery.
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anthony Doufas
Professor of Anesthesiology, Perioperative and Pain Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anthony Doufas, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor, Department of Anesthesiology, Stanford University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-70628
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.